Neutral
West completes sale of on-body drug delivery device to AbbVie
West Pharmaceutical Services announced the completion of the sale of its SmartDose 3.5mL on-body delivery system, including manufacturing and supply r...
Neutral
West Pharmaceutical Services announced the completion of the sale of its SmartDose 3.5mL on-body delivery system, including manufacturing and supply r...
Bullish
West Pharmaceutical Services (WST) stock has seen a 13% surge over a 9-day winning streak, increasing its market cap by $3.0 billion to $26 billion. D...
Neutral
This article from Investing.com reports the filing of a Form 4 by West Pharmaceutical Services Inc. on July 1st. The filing pertains to West Pharmaceu...
Neutral
West Pharmaceutical Services Inc. director Janet Brutschea Haugen has been awarded 46 new Phantom Stock Units and holds 791 restricted stock units (RS...
Bullish
West Pharmaceutical Services (WST) reported a 21% revenue growth, driven by strong demand for its advanced drug delivery systems. This performance hig...
Bullish
West Pharmaceutical Services (WST) stock has reached a new 52-week high of $363.38, reflecting a 64.01% increase over the past year. The company, with...
Neutral
West Pharmaceutical Services (WST) stock has reached a new 52-week high of $338.73, marking a 52.2% increase over the past year. The company, valued a...
West Pharmaceutical Services (WST) is experiencing increased investor interest due to the rising demand for GLP-1 therapies, which highlight its injec...
Neutral
BLI Banque de Luxembourg Investments lowered its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 5.7% in the fourth ...